VERS Verseon Corporation

TIDMVERS

RNS Number : 4392R

Verseon Corporation

29 October 2019

October 29, 2019

Verseon Corporation

("Verseon" or the "Company")

Result of 2019 AGM

Fremont, Calif.-Verseon Corporation (AIM: VERS), a clinical-stage pharmaceutical company, announces that all resolutions put to shareholders during the Annual General Meeting ("AGM") held on October 28, 2019 at 9:00 am PDT were duly passed.

-Ends-

For further information, please contact

 
 Verseon Corporation                                www.verseon.com 
 Sebastian Wykeham / Tina Schlafly                +1 (510) 225 9000 
 
 Arden Partners (NOMAD and Broker) 
 Ruari McGirr / Ciaran Walsh / Dan Gee-Summons 
  (Corporate Finance) / Fraser Marshall             +44 (0) 20 7614 
  (Equity Sales)                                               5900 
 

For trade and pharma media enquiries, please contact

 
 Vane Percy & Roberts 
                         +44 (0) 1737 821 
 Simon Vane Percy                     890 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGPGGWAUUPBUAB

(END) Dow Jones Newswires

October 29, 2019 03:00 ET (07:00 GMT)

Grafico Azioni Verseon (LSE:VERS)
Storico
Da Mar 2024 a Apr 2024

Grafico Azioni Verseon (LSE:VERS)
Storico
Da Apr 2023 a Apr 2024